Director TitleAgeSince
Director/Board Member - 2010-09-30
Director/Board Member - 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+179,900.00%-14.29% - - 172K
-1.61%-1.27%+13.40%+59.79% 46.78B
-1.02%-3.01%+36.66%+100.50% 37.88B
+2.19%+3.78%+12.21%+79.75% 11.82B
+1.32%+1.54%-10.59%+12.87% 11.61B
-0.95%-0.38%+17.65%+146.45% 9.12B
+0.39%+2.39%+29.99%+38.63% 7.38B
+1.30%+1.34%+19.83%+185.74% 7.12B
-0.06%+1.94%+39.71%-18.67% 7.21B
+0.70%-2.06%-42.22%+7.42% 4.99B
Average +17,990.23%+0.45%+12.96%+68.05% 15.99B
Weighted average by Cap. -0.24%-0.09%+18.32%+73.26%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-
  1. Stock Market
  2. Stocks
  3. PVTTF Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!